-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Kiniksa Pharmaceuticals International, plc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2017 to Q3 2024.
- Kiniksa Pharmaceuticals International, plc Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$12.7M, a 8.39% increase year-over-year.
- Kiniksa Pharmaceuticals International, plc Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$9.07M, a 35.5% decline year-over-year.
- Kiniksa Pharmaceuticals International, plc annual Net Income (Loss) Attributable to Parent for 2023 was $14.1M, a 92.3% decline from 2022.
- Kiniksa Pharmaceuticals International, plc annual Net Income (Loss) Attributable to Parent for 2022 was $183M.
- Kiniksa Pharmaceuticals International, plc annual Net Income (Loss) Attributable to Parent for 2021 was -$158M, a 2.14% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)